Specify a stock or a cryptocurrency in the search bar to get a summary
Avecho Biotechnology Ltd
OEZAvecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. The company was incorporated in 1992 and is based in Clayton, Australia. Address: 2A Westall Road, Clayton, VIC, Australia, 3168
Analytics
WallStreet Target Price
2.6 AUDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures OEZ
Dividend Analytics OEZ
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
–Dividend History OEZ
Stock Valuation OEZ
Financials OEZ
Results | 2019 | Dynamics |